InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 197145

Tuesday, 11/25/2014 8:16:25 AM

Tuesday, November 25, 2014 8:16:25 AM

Post# of 346493
Scott Antonia : Peregrine Pharmaceuticals KOL :

Prelude To A Cure

Arming Your Immune System to Kill Cancer

One of the reasons cancer cells are so insidious is because of their ability to invade healthy cells and convert them into cancerous ones. They accomplish this while staying under the radar of the immune system.

In the past, chemical based treatments designed to attack cancer cells damaged both good and bad cells, and were very difficult for the patient to endure. Thanks to Dr. Antonia’s research team, healthier alternatives are being explored.

“The focus of my research is on immune-based treatments. This approach unlocks a patients own immune system so it attacks any cancerous tumors,” said Dr. Scott Antonia

...
...
..
.
http://www.preludetoacure.com/finding-the-cure



.... nice quotes throughout the article from Scott Antonia.... is it PS Targeting ? I believe so

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News